Opis działalności
CytoTools AG is a biotechnology company focused on translating fundamental biology research on the mechanisms of cell growth and programmed cell death into unique therapies that are designed to treat the cause of the disease rather than the symptoms. The Company has developed a robust and diverse pipeline of disease modifying therapies that comprise proprietary small molecules and biologics. These have the potential to provide new treatment options in dermatology, cardiology and angiology, urology and oncology.
Zarząd & Rada nadzorcza
| CEO |
| Dr. Mark-Andre Freyberg |
| Zarząd |
| Marc Herwick, Dr. Dirk Kaiser |
| Rada nadzorcza |
| Dr. Bernhard Seehaus, Dr. Manfred May, Dr. Rüdiger Weseloh, Heiner Hoppmann, Matthias Hoffmann |
Dane firmy
| Nazwa: |
CytoTools AG |
| Adres: |
Klappacher Straße 126,D-64285 Darmstadt |
| Telefon: |
+49-6151-951-5812 |
| Fax: |
+49-6151-951-5813 |
| E-mail: |
kontakt@cytotools.de
|
| Internet: |
www.cytotools.de/ |
| Przemysł: |
Biotechnologia |
| Sektor: |
Biotechnologia |
| Podsektor: |
Biotechnologia |
| Koniec roku finansowego: |
31.12 |
| Free float: |
53,00% |
| Data IPO: |
- |
Relacje inwestorskie
| Nazwa: |
Dr. Mark-Andre Freyberg |
| Telefon: |
- |
| Fax: |
- |
| E-mail: |
-
|
